Market Tracker

12/02 5:16pm ET

Albany Molecular Research Inc (NASDAQ:AMRI)

16.23
Delayed Data
As of Dec 02
 -0.16 / -0.98%
Today’s Change
12.45
Today|||52-Week Range
20.65
-18.24%
Year-to-Date
No recent news for Albany Molecular Research Inc.

Today’s Trading

Previous close16.39
Today’s open16.39
Day’s range16.15 - 16.57
Volume189,665
Average volume (3 months)256,210
Market cap$696.1M
Dividend yield--
Data as of 4:00pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+30.00%
Earnings growth (this year)+12.15%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+45.48%
P/E ratioNM
Price/Sales1.64
Price/Book2.01

Competitors

 Today’s
change
Today’s
% change
RGNXRegenxbio Inc+0.20+0.89%
AMRNAmarin Corporation P...+0.09+2.92%
BSTCBiospecifics Technol...+0.46+0.94%
CDXSCodexis Inc-0.20-4.30%
Data as of 4:00pm ET, 12/02/2016

Financials

Next reporting dateFebruary 7, 2017
EPS forecast (this quarter)$0.50
Annual revenue (last year)$402.4M
Annual profit (last year)-$2.3M
Net profit margin-0.57%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
William S. Marth
Chief Operating Officer
George Svokos
Corporate headquarters
Albany, New York

Forecasts